OBI & OTRADI August 2020 Newsletter

OBI Appoints Two New Members to Its Board of Directors

 

Aditi Martin was recently elected as an OBI/OTRADI Board Director. She is the Senior Director of Collaborations and Entrepreneurship at Oregon Health and Science University (OHSU). Aditi is a strategy and innovation professional with extensive experience in building partnership and negotiating a variety of commercialization agreements. She was also a recipient of Portland Business Journal’s 2018 Forty under 40.

 

Ken Wilson was recently elected as an OBI/OTRADI Board Director. He is the Vice President of Campus Development at Oregon Museum of Science and Industry (OMSI). Ken is a multifaceted real estate executive with expertise in transactions, project management, portfolio management, sourcing and managing outside vendors, managing in house real estate departments as well as third party providers. In his role at OMSI he is responsible for leading the organization’s development of 11 riverfront acres around the museum’s primary facilities.

Welcome RAW Molecular Systems to the OBI!

Our newest client company is RAW Molecular Systems. Their services include biological pathogen monitoring to tackle untreatable antibiotic/antifungal resistant diseases or diseases without current therapy for plants, animals, and people. We are excited to have them join us, and they have hit the ground running with some great wins last month:

Congratulations to the team at RAW!

More OBI Client Company Wins

Veana Therapeutics is pleased to share a joint Veana Therapeutics-University of Washington press release of a Phase 1 trial in HER2+ breast cancer patients at the University of Washington. The trial is now open and is enrolling patients.

Promedix, Inc. was awarded a 2021 Pediatric Medical Device Funding Grant from the Consortium for Technology and Innovation in Pediatrics, an FDA pediatric device consortium. This funding will further develop regulatory strategy and a recently launched clinical trial at OHSU in the intensive care unit.

SUTUREGARD Medical, Inc. shares their wins:

Health Technology Innovations, Inc. presented poster sessions on CryoDiscovery at the ACA 2020 (American Crystallographic Association) and M&M 2020 (Microscopy & Microanalysis) events August 2nd-7th. CryoDiscovery is a machine learning platform for cryo-electron microscopy (cryo-EM) image processing, currently in Alpha stage testing at OHSU and University of Washington, showing strong results.

Caregiven was recently profiled by HITLab and their Women’s Health Tech Initiative. This profile includes the creation of a case study they are planning to share with their stakeholders in the coming weeks. Caregiven is also making great strides in their platform content following their research with Particle Design.

Last month we reported on Hemex Health‘s release of their Gazelle Diagnostic platform for malaria and sickle cell disease. Hemex Health also has a strong collaboration with Novartis, which is focused on Sickle Cell Disease treatment in Ghana. Novartis recently featured Hemex in their company’s World Sickle Cell Day video.

Madorra‘s recent wins:

Bend Venture Conference Applications Open Until August 13

One of the features of the Bend Venture Conference (BVC) is an Early Stage competition. Companies applying in the early stage competition typically:

All applicants, regardless of whether or not they are a finalist, have the opportunity to receive feedback from the investor group. The winner of this category could be awarded a minimum $30,000* investment, courtesy of Portland Seed Fund. Applications must be received by August 13, 2020. See details and apply here.

In addition, Portland Seed Fund is also offering limited Early Stage Access Scholarships and coaching. To be considered for a scholarship, at least one company founder should identify as BIPOC (Black, Indigenous, People of Color) and have a financial barrier to the company’s ability to participate in the conference. For more detailed information and how to apply, please see the BVC Early Stage Competition and Scholarship page.

Apply Now for the 2021 Beaverton Startup Challenge

In its 6th year, the Beaverton Startup Challenge is a collaboration of the City of Beaverton, the Westside Startup Fund, and the Oregon Technology Business Center (OTBC). Each year, they select five Startup Challenge companies who receive:

For more information, see the Beaverton Startup Challenge FAQ. To apply, use this link.

Need Seed Funding? Deadlines Approaching Soon

National Science Foundation’s America’s Seed Fund (SBIR-STTR) invests up to $1.75 million in seed funding for early-stage research and development, and takes no equity in your company. Submit a project pitch now, before September 3, 2020. Details here.

The National Institutes of Health (NIH) SBIR/STTR funding application proposal dates are September 5, 2020; January 5 and April 5, 2021. For more information on what the NIH funding entails, see this link.

Upcoming Events

OBI Virtual Lunch & Learn: Valuation of Life Science Companies
August 11, 2020
12:00-1:00 PM
Register soon – nearly sold out!

 

TIE Women Pitch Competition
Applications due August 14, 2020
Pitch Competition September 2, 2020
Details here

 

TAO Virtual Cybersecurity Meetup
August 20, 2020
11:00 AM-12:00 PM
More information and registration

 

Badass Womxn Entrepreneurs
August 25, 2020
4:00-5:30 PM
Free to attend

 

TRAILS Competition Launch: Bringing Solutions to Palliative Care
Kicks off September 9, 2020
12:00-1:00 PM
More information here

 

VertueLab Cleantech Innovation Summit FUEL 2020
September 9-25, 2020
All the details here

 

Oregon Bioscience Association Biotech Summit
September 16, 2020
9:00 AM-1:30 PM
More information

 

Technology Association of Oregon 2020 Technology Awards
September 23, 2020
3:00-5:00 PM
Register here

 


Oregon Bioscience Association has converted their
BioPro classes to a new virtual format!
Link to full class schedule